Actos Linked to Bladder Cancer According to New Study

Share Article

Findings of the study published on July 3rd 2012, in the Canadian Medical Association Journal, revealed that Actos (pioglitazone) is linked to increased risk of bladder cancer. Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance. According to court documents, on June 12, 2012, New York resident, Wanda Heavey, filed a $10 million lawsuit in New York Eastern District Court (case no. 2:2012cv02945) alleging she suffered bladder cancer as a result of her use of the drug Actos. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Actos severe adverse events. [http://www.attorneyone.com/actos/

Actos: severe adverse events threat

Actos: severe adverse events threat

thiazolidinediones, particularly pioglitazone, are associated with an increased risk of bladder cancer among adults with type 2 diabetes

The media spotlight is often a double-edged sword. No one knows this better than Wanda Heavey and people who filed an Actos Lawsuit. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

Findings of the study published on July 3rd 2012, in the Canadian Medical Association Journal, revealed that Actos (pioglitazone) is linked to increased risk of bladder cancer. Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance. Study background informs that patients with type 2 diabetes have a 40% increased risk of bladder cancer. And the interpretation mentions that the limited evidence available supports the hypothesis that thiazolidinediones, particularly pioglitazone, are associated with an increased risk of bladder cancer among adults with type 2 diabetes.

According to court documents, on June 12, 2012, New York resident, Wanda Heavey, filed a $10 million lawsuit in New York Eastern District Court (case no. 2:2012cv02945) alleging she suffered bladder cancer as a result of her use of the drug Actos. Plaintiff claims she started taking Actos to treat her type 2 diabetes in January 2005 and she continued taking it consistently until about 2010. She was diagnosed with bladder cancer in December 2010. This lawsuit has been transferred to the current Actos Multi District Litigation (MDL 2299) in the Western District of Louisiana.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Actos, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Actos remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In June 2011, the FDA required a new safety label stating that: “The use of Actos for more than one year may increase a person’s chance of bladder cancer”.

AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/7/prweb9723620.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Visit website